Sinusitis and Rhinitis VA Claims: Separate Ratings, Polyps, and PACT Act Rules

Chronic sinusitis and allergic rhinitis are frequently claimed together by veterans exposed to airborne hazards. Because sinusitis affects the mucous membranes of the paranasal sinus cavities (maxillary, frontal, ethmoid, or sphenoid) while rhinitis affects the nasal passages and nasal turbinates, the two conditions represent distinct anatomical pathologies. Under 38 CFR 4.14, veterans can lawfully receive separate disability ratings for both conditions without violating the rule against pyramiding.

Sinusitis is evaluated under Diagnostic Codes 6510 through 6514 based on the annual frequency of antibiotic-treated episodes: 0% for sinusitis detected by X-ray or CT scan without acute symptoms; 10% for one or two prolonged antibiotic courses (4 to 6 weeks) per year, or 3 to 6 shorter antibiotic courses (1 to 2 weeks); 30% for three or more prolonged antibiotic courses per year, or more than six shorter courses; and 50% for radical sinus surgery with osteomyelitis or near-continuous episodes.

Rhinitis is evaluated under Diagnostic Code 6522 at 10% or 30%: a 10% rating is assigned when physical examination demonstrates greater than 50% obstruction of nasal passages on both sides, or complete (100%) obstruction on one side; a 30% rating is assigned when clinical examination or nasal endoscopy confirms the presence of nasal polyps, regardless of whether prior polyp surgery was performed if symptoms persist.

Both chronic sinusitis and chronic rhinitis are designated presumptive conditions under the PACT Act (38 CFR 3.320). Veterans who deployed to qualifying locations in the Southwest Asia theater, Afghanistan, or other designated exposure areas are presumed service-connected upon presenting a clinical diagnosis, without needing to submit an independent medical nexus linking the condition to military service.

Successful claims for sinusitis and rhinitis require comprehensive documentation: high-resolution CT scans of the facial bones and paranasal sinuses showing mucosal thickening, otolaryngology (ENT) records confirming polyp presence, and complete pharmacy records detailing each antibiotic prescription and topical nasal steroid course prescribed over the previous 12 months.